Clinical trial · Observational
Metabolic Syndrome in Childhood Cancer Survivors
NCT00920738CI-TRIAL-00015451completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Gathering information about how often metabolic syndrome occurs in young survivors of childhood cancer may help doctors learn more about the disease. PURPOSE: This clinical trial is studying metabolic syndrome in survivors of childhood cancer and in their healthy sisters and brothers.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| metabolic assessment | Other | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Cancer Survivors
- description
- Subjects who are cancer survivors must have survived childhood cancer (diagnosed \< or = 18 years) for a minimum of 5 years and be in remission.
- interventionNames
- Other: metabolic assessment
- Other: questionnaire administration
- label
- Healthy Siblings of Cancer Survivor
- description
- Healthy populations similar in age and gender distribution, derived from a frequency matched control population of 350 healthy siblings.
- interventionNames
- Other: metabolic assessment
- Other: questionnaire administration
Primary outcomes (4)
- measure
- Metabolic syndrome (MS) in survivors of childhood cancer (CCS) vs controls
- timeFrame
- Day 1 and Day 2
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 9 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects must be survivors of childhood cancer, treated at Fairview-University Medical Center or Children's Hospitals and Clinics of Minneapolis and St Paul or siblings of survivors. * Subjects will be 9-17 years old at the time of their visit. * Subjects who are cancer survivors must have survived childhood cancer for a minimum of 5 years and be in remission. Exclusion Criteria: * Eligibility will not be restricted by race or sex. * Any women currently pregnant will not be eligible, but may participate 3 or more months after the end of her pregnancy if the study is still ongoing. * Subjects who underwent hematopoietic cell transplant (HCT) are not eligible for this study.
References
Publications (0)
Data not yet available
No reference posted for this study.